Switching among biologic therapies is common practice in patients with rheumatoid arthritis who have an inadequate response or intolerable adverse events. Evidence from observational studies and ...

"Fulcrum maybe isn't the most trendy investor, but we care a lot about what has real impact on the farm," says Amber DeWitt.

Infinitopes, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today ...

Q3 2024 Earnings Call Transcript November 8, 2024 Amneal Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Prior to Pfizer’s investment and acquisition, Bamboo had been operating as a virtual company with seed money from angel investors ... Pfizer and Bamboo colleagues’ deep scientific understanding of ...

That loan and a small convertible note acted as our seed funding to allow us to get our first partners and start building ... Microglassification itself uses solvents to dehydrate small droplets of a ...

Atezolizumab Plus Bevacizumab-induced Recalcitrant Pyoderma Gangrenosum Treated with Baricitinib: A Case Report.

Infinitopes' lead vaccine candidate ITOP1 is a novel, precision targeted, immunologically durable, "off-the-shelf" cancer vaccine, designed to save lives by preventing disease recurrence in first-line ...